Literature DB >> 17197098

Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area.

A Lessard1, E F Grady, N W Bunnett, V M Pickel.   

Abstract

Neurokinin-3 (NK(3)) receptors are prevalent within the substantia nigra (SN) and ventral tegmental area (VTA), where their activation can affect motor and motivational behaviors as well as cardiovascular function and stress responses. These actions are mediated, in part, by dopaminergic neurons in each region. To determine the relevant sites for activation of these receptors, we examined the electron microscopic localization of NK(3) receptors and tyrosine hydroxylase (TH), the catecholamine synthesizing enzyme in dopaminergic neurons in the SN and VTA of rat brain. In each region, immunogold-silver labeling for NK(3) receptors was detected in many somatodendritic profiles, some of which contained TH-immunoreactivity. NK(3)-immunogold particles were largely associated with endomembranes resembling smooth endoplasmic reticulum, and only occasionally located on the plasma membrane in TH-labeled dendrites. In comparison with these dendrites, non-TH immunoreactive dendrites contained significantly more total (VTA) and more plasmalemmal (VTA and SN) NK(3)-immunogold particles. In each region, NK(3) gold particles also were seen in axonal as well as glial profiles, some of which contacted TH-immunoreactive dendrites. The NK(3)-labeled axon terminals formed either symmetric or asymmetric, excitatory-type synapses, the latter of which were significantly more prevalent in the VTA, compared with SN. These results provide the first ultrastructural evidence indicating that NK(3) receptors are available in cytoplasmic reserve in dopaminergic neurons, but more immediately accessible at the plasmalemmal surface of non-dopaminergic dendrites in both the SN and VTA. The activation of these receptors, together with the NK(3) receptors in either the presynaptic axon terminals or glia may contribute to the diverse physiological effects of tachykinins in each region, and most prominently involving excitatory inputs to the VTA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17197098     DOI: 10.1016/j.neuroscience.2006.10.058

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Substance P inhibits GABAB receptor signalling in the ventral tegmental area.

Authors:  Yan-Fang Xia; Elyssa B Margolis; Gregory O Hjelmstad
Journal:  J Physiol       Date:  2010-03-15       Impact factor: 5.182

Review 2.  Diverse roles of G-protein coupled receptors in the regulation of neurohypophyseal hormone secretion.

Authors:  C D Sladek; Z Song
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

3.  Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.

Authors:  Helaine De Brito Gariepy; Réjean Couture
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  The neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area.

Authors:  Andrée Lessard; Martin Savard; Fernand Gobeil; Joseph P Pierce; Virginia M Pickel
Journal:  Synapse       Date:  2009-06       Impact factor: 2.562

Review 5.  The pharmacology of neurokinin receptors in addiction: prospects for therapy.

Authors:  Alexander J Sandweiss; Todd W Vanderah
Journal:  Subst Abuse Rehabil       Date:  2015-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.